Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma

HIROKI ISHIHARA, TOSHIO TAKAGI, TSUNENORI KONDO, HIRONORI FUKUDA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, MASAYOSHI OKUMI, HIDEKI ISHIDA and KAZUNARI TANABE
In Vivo May 2020, 34 (3) 1541-1546; DOI: https://doi.org/10.21873/invivo.11943
HIROKI ISHIHARA
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIO TAKAGI
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUNENORI KONDO
2Department of Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kondo.tsunenori{at}twmu.ac.jp
HIRONORI FUKUDA
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEKAZU TACHIBANA
2Department of Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIKO YOSHIDA
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNPEI IIZUKA
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAYOSHI OKUMI
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEKI ISHIDA
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUNARI TANABE
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 34 no. 3 1541-1546
DOI 
https://doi.org/10.21873/invivo.11943
PMID 
32354960

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received March 9, 2020
  • Revision received March 21, 2020
  • Accepted March 24, 2020
  • Published online April 29, 2020.

Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. HIROKI ISHIHARA1,
  2. TOSHIO TAKAGI1,
  3. TSUNENORI KONDO2⇑,
  4. HIRONORI FUKUDA1,
  5. HIDEKAZU TACHIBANA2,
  6. KAZUHIKO YOSHIDA1,
  7. JUNPEI IIZUKA1,
  8. MASAYOSHI OKUMI1,
  9. HIDEKI ISHIDA1 and
  10. KAZUNARI TANABE1
  1. 1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
  2. 2Department of Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
  1. Correspondence to: Tsunenori Kondo, Department of Urology, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo 116-8567, Japan. Tel: +81 338101111, Fax: +81 358556319, e-mail: kondo.tsunenori{at}twmu.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 34, Issue 3
May-June 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma
HIROKI ISHIHARA, TOSHIO TAKAGI, TSUNENORI KONDO, HIRONORI FUKUDA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, MASAYOSHI OKUMI, HIDEKI ISHIDA, KAZUNARI TANABE
In Vivo May 2020, 34 (3) 1541-1546; DOI: 10.21873/invivo.11943

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma
HIROKI ISHIHARA, TOSHIO TAKAGI, TSUNENORI KONDO, HIRONORI FUKUDA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, MASAYOSHI OKUMI, HIDEKI ISHIDA, KAZUNARI TANABE
In Vivo May 2020, 34 (3) 1541-1546; DOI: 10.21873/invivo.11943
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Effects of Short-term High-dose Vitamin D Supplementation on Mineral Homeostasis in Healthy Young Adults
  • Impact of Heart Dose on Survival in Palliative Radiotherapy for Bone Metastases: Propensity Score-matched Analysis
  • Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer
Show more Clinical Studies

Keywords

  • RCC
  • ICI
  • targeted therapy
  • PD-1
  • PD-L1
  • subsequent therapy
In Vivo

© 2026 In Vivo

Powered by HighWire